Chuong D Hoang
Thoracic and Gastrointestinal Oncology Branch, CCR
National Cancer Institute
United States of America
Dr. Hoang received his medical degree from the University of Minnesota Medical School, where he stayed to complete clinical training in general surgery. During his surgical residency his research work was supported by the Ruth L. Kirschstein National Research Service Award and a Training Program Grant in the Division of Hematology-Oncology. Afterwards, Dr. Hoang completed his cardiothoracic residency at the University of Pennsylvania, with an emphasis on thoracic surgery. Since 2008, he then served on faculty at Stanford University School of Medicine as an Assistant Professor. He was the Medical (co-)Director of the Stanford Cancer Center Tissue Bank. Dr. Hoang also established an independent thoracic oncology laboratory there investigating the metabolic derangements in lung cancer and microRNA interactions in mesothelioma. Dr. Hoang's research focus is in thoracic surgical oncology, with emphasis on malignant mesothelioma and thymic neoplasms. His clinical expertise includes all the major aspects of thoracic surgery including procedures for lung cancer, other primary lung tumors, mesothelioma, thymic malignancies, esophageal cancer, pulmonary metastases, Pancoast tumors, and tracheal cancers. He utilizes the latest techniques in endoscopic and minimally-invasive thoracic surgery. He is developing a laboratory effort in translating deranged microRNA profiles unique to mesothelioma and other thoracic cancers for biomarker discovery and novel therapeutic strategies.
1) Non-small cell lung cancer, 2) Mesothelioma, 3) Thymic tumors, 4) Esophageal cancer, 5) Pulmonary metastatic cancers, 6) Minimally invasive thoracic surgery, 7) Cancer Biology, 8) Molecular Biology and Biochemistry, 9) novel biomarkers and therapeutic strategies in malignant mesothelioma by systematically identifying and exploiting disease-specific microRNA
A rare population of CD24(+)ITGB4(+)Notch(hi) cells drives tumor propagation in NSCLC and requires Notch3 for self-renewal.
Liquid chromatography/mass spectrometry methods for measuring dipeptide abundance in non-small-cell lung cancer.
miR-1 induces growth arrest and apoptosis in malignant mesothelioma.